Abstract
Medicalization is frequently defined as a process by which some non-medical aspects of human life become to be considered as medical problems. Overdiagnosis, on the other hand, is most often defined as diagnosing a biomedical condition that in the absence of testing would not cause symptoms or death in the person’s lifetime. Medicalization and overdiagnosis are related concepts as both expand the extension of the concept of disease. They are both often used normatively to critique unwarranted or contested expansion of medicine and to address health services that are considered to be unnecessary, futile, or even harmful. However, there are important differences between the concepts, as not all cases of overdiagnosis are medicalizations and not all cases of medicalizations are overdiagnosis. The objective of this article is to clarify the differences between medicalization and overdiagnosis. It will demonstrate how the subject matter of medicalization traditionally has been non-medical (social or cultural everyday life) phenomena, while the subject matter of overdiagnosis has been biological or biomolecular conditions or processes acknowledged being potentially harmful. They also refer to different types of uncertainty: medicalization is concerned with indeterminacy, while overdiagnosis is concerned with lack of prognostic knowledge. Medicalization is dealing with sickness (sick role) while overdiagnosis with disease. Despite these differences, medicalization and overdiagnosis are becoming more alike. Medicalization is expanding, encompassing the more “technical” aspects of overdiagnosis, while overdiagnosis is becoming more ideologized. Moreover, with new trends in modern medicine, such as P4 (preventive, predictive, personal, and participatory) medicine, medicalization will become all-encompassing, while overdiagnosis more or less may dissolve. In the end they may converge in some total “iatrogenization.” In doing so, the concepts may lose their precision and critical sting.
Similar content being viewed by others
References
Abraham, J. 2010. Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions. Sociology 44: 603–622.
Ballard, K., and M. Elston. 2005. Medicalisation: A multi-dimensional concept. Social Theory & Health 3: 228–241.
Bandini, J. 2015. The medicalization of bereavement: (Ab)normal grief in the DSM-5. Death Studies 39: 347–352.
Barker, K. K. 2010. The social construction of illness. In Handbook of medical sociology, ed. C.E. Bird, P. Conrad, A.M. Fremont, and S. Timmermans, 147–159. Nashville: Vanderbilt University Press.
Bell, S.E., and A.E. Figert. 2012. Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward. Social Science and Medicine 75: 775–783.
Boorse, C. 1975. On the distinction between disease and illness. Philosophy & Public Affairs 5: 49–68.
Boorse, C. 2014. A second rebuttal on health. Journal of Medicine and Philosophy 39: 683–724.
Carter, J.L., R.J. Coletti, and R.P. Harris. 2015a. Quantifying and monitoring overdiagnosis in cancer screening: A systematic review of methods. BMJ 350: g7773.
Carter, S.M., W. Rogers, I. Heath, C. Degeling, J. Doust, and A. Barratt. 2015b. The challenge of overdiagnosis begins with its definition. BMJ 350: h869.
Chen, R., G.I. Mias, J. Li-Pook-Than, L. Jiang, H.Y. Lam, R. Chen, E. Miriami, K.J. Karczewski, M. Hariharan, F.E. Dewey, Y. Cheng, M.J. Clark, H. Im, L. Habegger, S. Balasubramanian, M. O’huallachain, J.T. Dudley, S. Hillenmeyer, R. Haraksingh, D. Sharon, G. Euskirchen, P. Lacroute, K. Bettinger, A.P. Boyle, M. Kasowski, F. Grubert, S. Seki, M. Garcia, M. Whirl-carrillo, M. Gallardo, M.A. Blasco, P.L. Greenberg, P. Snyder, T.E. Klein, R.B. Altman, A.J. Butte, E.A. Ashley, M. Gerstein, K.C. Nadeau, H. Tang, and M. Snyder. 2012. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148: 1293–1307.
Cipolla, C. 2010. Why we cannot consider ourselves Darwinists anymore (Why Dunant won over Darwin). Salute e Società 9: 138–142.
Clark, J. 2014. Medicalization of global health 1: Has the global health agenda become too medicalized? Global Health Action. doi:10.3402/gha.v7.23998.
Clarke, A.E., J.K. Shim, L. Mamo, J.R. Fosket, and J.R. Fishman. 2003. Biomedicalization: Technoscientific transformations of health, illness, and US biomedicine. American Sociological Review 68(2): 161–194.
Conrad, P. 1992. Medicalization and social control. Annual review of Sociology 18: 209–232.
Conrad, P. 2005. The shifting engines of medicalization. Journal of Health and Social Behavior 46: 3–14.
Conrad, P. 2007. The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore: Johns Hopkins University Press.
Conrad, P., and K.K. Barker. 2010. The social construction of illness: Key insights and policy implications. Journal of Health and Social Behavior 51: S67–S79.
Davis, J.E. 2010. Medicalization, social control, and the relief of suffering. In The new Blackwell companion to medical sociology, ed. W. Cockerham, 211–241. Chisester: Blackwell Publisher.
de Gelder, R., E.A. Heijnsdijk, N.T. Van Ravesteyn, J. Fracheboud, G. Draisma, and H.J. De Koning. 2011. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiologic Reviews 33: 111–121.
Duster, T. 2007. Medicalisation of race. The Lancet 369: 702–704.
Earp, B.D., A. Sandberg, and J. Savulescu. 2015. The medicalization of love. Cambridge Quarterly of Healthcare Ethics 24: 323–336.
Fabrega Jr, H. 1980. The idea of medicalization: An anthropological perspective. Perspectives in Biology and Medicine 24: 129–142.
Flores, M., G. Glusman, K. Brogaard, N.D. Price, and L. Hood. 2013. P4 medicine: How systems medicine will transform the healthcare sector and society. Personalized Medicine 10: 565–576.
Frosch, D.L., D. Grande, D.M. Tarn, and R.L. Kravitz. 2010. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health 100: 24–32.
Garry, A. 2001. Medicine and medicalization: A response to Purdy. Bioethics 15: 262–269.
Goh, C.R. 2012. Medicalization of dying: Are we turning the corner? Journal of Palliative Medicine 15: 728–729.
Hacking, I. 1999. The social construction of what? Cambridge, MA: Harvard University Press.
Heath, I. 2013. Overdiagnosis: When good intentions meet vested interests—An essay by Iona Heath. BMJ 347: f6361.
Hofmann, B. 2001. The technological invention of disease. Medical Humanities 27: 10–19.
Hofmann, B. 2014. Diagnosing overdiagnosis: Conceptual challenges and suggested solutions. European Journal of Epidemiology 29: 599–604.
Hofmann, B.M. 2015. Too much technology. BMJ 350: h705.
Hofmann, B. 2016. Obesity as a socially defined disease: Philosophical considerations and implications for policy and care. Health Care Analysis 24: 86–100.
Hood, L. 2013. Systems biology and p4 medicine: Past, present, and future. Rambam Maimonides Medical Journal 4: e0012.
Hood, L., R. Balling, and C. Auffray. 2012. Revolutionizing medicine in the 21st century through systems approaches. Biotechnology Journal 7: 992–1001.
Hood, L., J.C. Lovejoy, and N.D. Price. 2015. Integrating big data and actionable health coaching to optimize wellness. BMC Medicine 13: 4.
Hood, L., and N.D. Price. 2014. Demystifying disease, democratizing health care. Science Translational Medicine 6: 225ed5.
Horwitz, A., and J. Wakefield. 2007. The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
Illich, I. 1976. Medical nemesis: The expropriation of health. New York: Random House.
Lin, G.A., R.A. Dudley, and R.F. Redberg. 2008. Why physicians favor use of percutaneous coronary intervention to medical therapy: A focus group study. Journal of General Internal Medicine 23: 1458–1463.
Lippman, A. 1998. The politics of health: Geneticization versus health promotion. In The politics of women’s health: Exploring agency and autonomy, ed. S. Sherwin. Philadelphia: Temple University Press.
Maturo, A. 2012. Medicalization: Current concept and future directions in a bionic society. Mens Sana Monographs 10: 122–133.
Metzl, J.M., and R.M. Herzig. 2007. Medicalisation in the 21st century: Introduction. The Lancet 369: 697–698.
Moynihan, R. 2003. The making of a disease: Female sexual dysfunction. BMJ 326: 45–47.
Moynihan, R., J. Doust, and D. Henry. 2012. Preventing overdiagnosis: How to stop harming the healthy. BMJ 344: e3502.
Moynihan, R., I. Heath, and D. Henry. 2002. Selling sickness: The pharmaceutical industry and disease mongering. BMJ 324: 886–891.
Moynihan, R., D. Henry, and K.G. Moons. 2014. Using evidence to combat overdiagnosis and overtreatment: Evaluating treatments, tests, and disease definitions in the time of too much. PLoS Medicine 11: e1001655.
Nessa, J., and K. Malterud. 1998. “Feeling your large intestines a bit bound”: Clinical interaction–talk and gaze. Scandinavian Journal of Primary Health Care 16: 211–215.
Nye, R.A. 2003. The evolution of the concept of medicalization in the late twentieth century. Journal of the History of the Behavioral Sciences 39: 115–129.
Payer, L. 2006. Disease-mongers: How doctors, drug companies, and insurers are making you feel sick. New York: Wiley.
Raffle, A., and J. Muir Gray. 2007. Screening: Evidence and practice. New York: Oxford University Press.
Rogers, W. 2015. Understanding overdiagnosis as a form of medicalisation. In 29th European conference on philosophy of medicine and health care. Ghent.
Rose, N. 2007. Beyond medicalisation. The Lancet 369: 700–702.
Sadler, J.Z., F. Jotterand, S.C. Lee, and S. Inrig. 2009. Can medicalization be good? Situating medicalization within bioethics. Theoretical Medicine and Bioethics 30: 411–425.
Schwartz, P.H. 2008. Risk and disease. Perspectives in Biology and Medicine 51: 320–334.
Scott, S. 2006. The medicalisation of shyness: From social misfits to social fitness. Sociology of Health & Illness 28: 133–153.
Svenaeus, F. 2015. What kind of creature is ADHD? Personalities and pathologies in the neuropsychiatric era. In 29th European conference on philosophy of medicine and health care. Basel: European Society for Philosophy in Medicine and Health Care.
Swan, M. 2009. Emerging patient-driven health care models: An examination of health social networks, consumer personalized medicine and quantified self-tracking. Int J Environ Res Public Health 6: 492–525.
Temple, L.K., R.S. Mcleod, S. Gallinger, and J.G. Wright. 2001. Defining disease in the genomics era. Science 293: 807–808.
Tomes, N. 2007. Patient empowerment and the dilemmas of late-modern medicalisation. Lancet 369: 698–700.
Topol, E. 2012. The creative destruction of medicine: How the digital revolution will create better health care. New York: Basic Books.
Tymstra, T. 1989. The imperative character of medical technology and the meaning of “anticipated decision regret”. International Journal of Technology Assessment in Health Care 5: 207–213.
Verweij, M. 1999. Medicalization as a moral problem for preventive medicine. Bioethics 13: 89–113.
Vogt, H., B. Hofmann, and L. Getz. 2016. The new holism: P4 systems medicine and the medicalization of health and life itself. Medicine, Health Care and Philosophy 1–17.
Wakefield, J.C. 2012. Should prolonged grief be reclassified as a mental disorder in DSM-5? Reconsidering the empirical and conceptual arguments for complicated grief disorder. The Journal of Nervous and Mental Disease 200: 499–511.
Wardrope, A. 2015. Medicalization and epistemic injustice. Medicine, Health Care and Philosophy 18: 341–352.
Welch, H.G., and W.C. Black. 2010. Overdiagnosis in cancer. Journal of the National Cancer Institute 102: 605–613.
Welch, H.G., and H.J. Passow. 2014. Quantifying the benefits and harms of screening mammography. JAMA Internal Medicine 174: 448–454.
Welch, H.G., L. Schwartz, and S. Woloshin. 2011. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press.
Wiener, R.S., L.M. Schwartz, and S. Woloshin. 2013. When a test is too good: How CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347: f3368.
Wynne, B. 1992. Uncertainty and environmental learning: Reconceiving science and policy in the preventive paradigm. Global Environmental Change 2: 111–127.
Zola, I. 1972. Medicine as an institution of social control. Sociological Review 20: 487–504.
Acknowledgments
This article is developed from a presentation held at the 29th European conference on philosophy of medicine and health care in Ghent August 2015. I am thankful for interesting discussions and wise comments from participants at the conference. I am also most grateful to two anonymous reviewers for excellent comments and wise suggestions that significantly have improved this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hofmann, B. Medicalization and overdiagnosis: different but alike. Med Health Care and Philos 19, 253–264 (2016). https://doi.org/10.1007/s11019-016-9693-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-016-9693-6